Cardiovascular consequences of laparoscopic surgery.
Struthers
A D
AD
Department of Clinical Pharmacology and Therapeutics, Ninewells Hospital, Dundee, Scotland, UK.
Cuschieri
A
A
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D001794:Blood Pressure / Q000502:physiology; D002245:Carbon Dioxide; D002302:Cardiac Output / Q000502:physiology; D004195:Disease Models, Animal; D004562:Electrocardiography; D006321:Heart / Q000503:physiopathology*; D006333:Heart Failure / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D010535:Laparoscopy / Q000009:adverse effects / Q000379:methods; D011028:Pneumoperitoneum, Artificial / Q000009:adverse effects / Q000379:methods; D011312:Pressure; D011651:Pulmonary Artery / Q000503:physiopathology; D014655:Vascular Resistance / Q000502:physiology; D014665:Vasodilator Agents / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D014665:Vasodilator Agents; D002245:Carbon Dioxide